%20Market.png)
Advanced therapeutics in aging and wellness represent a rapidly evolving segment within preventive healthcare, focusing on promoting healthy aging, longevity, and sustained physiological performance. This market includes clinically supported nutritional formulations, functional bioactives, and targeted supplementation strategies designed to address age-related changes in metabolism, cognition, immunity, cardiovascular health, and musculoskeletal function.
With increasing global life expectancy and a rising burden of chronic and degenerative diseases, healthcare systems and consumers are shifting from reactive treatments to proactive, prevention-driven approaches. Advanced therapeutics play a critical role in this transition by enabling individuals to maintain vitality, independence, and overall well-being as they age.
According to BIS Research, the advanced therapeutics (aging and wellness) market was valued at $154.89 billion in 2024 and is projected to reach $275.35 billion by 2035, growing at a CAGR of 5.51% during 2025-2035, highlighting strong long-term demand for preventive and nutrition-led health solutions.
Download the complete TOC and Request Sample Report
Key Drivers:
• aging population and rising life expectancy globally
• Increasing prevalence of metabolic and chronic diseases
• Shift toward preventive and longevity-focused healthcare approaches
• Rising demand for functional nutrition and science-backed supplements
• Advancements in aging biology, nutritional science, and bioactive ingredients
• Growing consumer awareness regarding product efficacy, transparency, and quality
According to Principal Analyst at BIS Research:
“The advanced therapeutics (aging and wellness) market is transitioning from a fragmented supplement-driven space to a structured, science-backed preventive healthcare segment. Driven by demographic shifts and increasing focus on longevity, demand for targeted nutrition-led interventions will continue to grow.
However, regulatory inconsistencies and limited clinical integration remain key barriers. Companies that emphasize clinical validation, advanced formulations, and scalable distribution strategies will be best positioned to capitalize on emerging opportunities. The market is expected to evolve toward precision-driven, outcome-oriented solutions aligned with healthcare systems globally.”
What is the expected growth outlook?
The market is projected to grow from $154.89 billion in 2024 to $275.35 billion by 2035, at a CAGR of 5.51%, driven by preventive healthcare adoption and aging demographics.
Who are the key leaders in this market?
Key players include Abbott Laboratories, Archer-Daniels-Midland Company, Amway Corp, Glanbia plc, Herbalife Ltd., Nestlé S.A., Orgain, LLC, Thorne HealthTech, Vitabiotics Ltd., and NOW Foods, among others.
Which segments are driving demand?
Functional nutrition dominates due to its wide applicability, while energy, endurance, and active aging applications lead demand owing to their relevance across broader populations.
Want to Make Data-Backed Moves in the Aging and Wellness Market?
BIS Research provides expert-driven insights, granular segmentation, and strategic advisory across healthcare, life sciences, and wellness domains.
Request a sample report
Book a Preview
Download the complete TOC
